U.S. Markets closed

Acura Pharmaceuticals, Inc. (ACUR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.44+0.02 (+4.51%)
At close: 3:49PM EDT
People also watch
ABIOAPRIALIMCLSNAEZS

Acura Pharmaceuticals, Inc.

616 N. North Court
Suite 120
Palatine, IL 60067
United States
847-705-7709
http://www.acurapharm.com

SectorHealthcare
IndustryDrug Delivery
Full Time Employees15

Key Executives

NameTitlePayExercisedAge
Mr. Robert B. JonesChief Exec. Officer, Pres and Director393kN/A58
Mr. Peter A. ClemensChief Financial Officer, Sr. VP and Sec.286kN/A64
Dr. Albert W. Brzeczko Ph.D.VP of Technical Affairs291kN/A60
Mr. James F. Emigh R.PH.VP of Corp. Devel.N/AN/A61
Mr. J. Bradley RivetVP of MarketingN/AN/A63
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.

Corporate Governance

Acura Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.